Pfizer Stock News

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that Frank DAmelio will retire from his position as Chief Financial Officer and Executive Vice President of Global Supply at Pfizer after a nearly 15 year distinguished career with the Company. Pfizer has initiated an external search for a new Chief Financial Officer and DAmelio has agreed to stay on board through this process and serve in a consulting role through the transition. With DAmelios planned departure, and his sig

Consumers are planning to splurge over the holidays, Apple on pace to set new iPhone sales record, Pfizer seeks FDA authorization for Covid-19 pill, and other news to start your day.

Study carried out by researchers at Johns Hopkins Medicine has shown that helper T cells produced by people who received either of Pfizer/BioNTech or Moderna vaccines for covid-19, persist six months after vaccination and recognize and help protect against the delta variant of SARS-CoV-2

New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc. Avelumab (BAVENCIO ® ) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or gastroesophageal junction adenocarcinomas (neoHERIZON) neoHERIZON will assess HER-Vaxx in combination with chemotherapy with or without avelumab in HER-2 positive gastric cancer SYDNEY, Australia., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Imugene (ASX: IMU) today announced a new clinical trial supply agreement with Merck KGaA, Darmstadt, Germany (ETR: MRK) and Pfizer Inc. (NYSE: PFE ) to evaluate the safety and efficacy of Imugene''s HER-Vaxx, a B-cell activating immunotherapy, in combination with avelumab, an immune checkpoint inhibitor targeting PD-L1, in patients with HER-2 positive gastric cancer. Avelumab, which is marketed as BAVENCIO ® , is co-developed and co-commercialized by Merck KGaA, Darmstadt, Germany and Pfizer Inc. neoHERIZON is an open-label, multi-center, randomized, Phase 2 clinical trial designed to assess the safety and efficacy of perioperative HER-Vaxx combined with chemotherapy with or without avelumab compared to chemotherapy alone in patients with HER-2 positive gastric or gastroesophageal junction adenocarcinomas.

Pharmaceutical giant Pfizer will allow generic manufacturers to supply its Paxlovid pill ; strict new Covid restrictions come into force for visitors to Beijing today Pfizer deal will allow generic versions of its Covid pill for worlds poor Auckland Covid travel restrictions to be lifted in December Germany set to tighten rules for unvaccinated people Fauci says good control of the virus in US is possible by spring See all our coronavirus coverage Welcome back to our live Covid news blog this Wednesday. Im Samantha Lock and Ill be with you for the next short while to give you a rundown of all the latest headlines. Continue reading

Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.

By MATTHEW PERRONE AP Health Writer WASHINGTON (AP) Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home. The companys filing comes as new infections are rising once again in the United States, [] The post Pfizer seeks approval of promising COVID-19 pill appeared first on Salisbury Post .

Pfizer''s booster shot may be available to all adults in America as early as this weekend.

US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world''s least-wealthy countries.

Pfizer announced on Tuesday that it will seek emergency authorization for Paxlovid, its antiviral pill to treat mild to moderate COVID-19, after clinical trials showed that the medication reduced hospitalization and death by 89% in those who took it in the first three to five days of symptoms. UPDATE: Today, Pfizer announced we are seeking [] The post Pfizer requests emergency authorization for its COVID antiviral pill first appeared on Conservative Institute .

Pfizer said it completed submission of its application for emergency use authorization (EUA) of the drug, Paxlovid, with the U.S. Food and Drug Administration, including data from the drugmaker''s clinical trial.

by Chris Black A monthly shot mandate is where the real money is. JPOST: No matter how old you are, two shots of Pfizer vaccine dont last No updates from

Washington, November 16 Pfizer Inc said on Tuesday it would allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licences to qualified generic drug manufacturers to make their own versions of PF-07321332. Reuters

Related Stocks: TXT , XOM , CRM , GD , LOW , ADI , PFE , GE , AZN , MRNA , LBTYK , SPGI , ALXN , WORK , MXIM , STEM , PCG , XLRN ,